CAR-T cells are revolutionizing the treatment of cancer and other diseases. A latest iteration in development involves fusion with an antigen-based CAR enhancer to provide low-affinity IL-2 signaling that might limit adverse effects.

中文翻译：

---

将全身性 IL-2 靶向 BCMA CAR-T 细胞


CAR-T 细胞正在彻底改变癌症和其他疾病的治疗。最新开发的迭代涉及与基于抗原的 CAR 增强子融合，以提供可能限制不良反应的低亲和力 IL-2 信号传导。